Search
Tractament antiviral de l'hepatitis C crònica a l'any 2019, 2020 i 2021: informe d'avaluació de resultats
(2022-02)
Minority diseases pose a major challenge to the health system, as they often have a genetic origin, can affect many organs, be serious, pose a vital threat, or be chronically debilitating. Their diagnosis is difficult, ...
Tractament de malalties minoritàries amb medicaments d'autorització individual a l'any 2019: informe d'avaluació de resultats
(2020)
Minority diseases pose a major challenge to the health system, as they are often of genetic origin and can affect many organs, be serious, pose a threat to life, or be chronically debilitating. Their diagnosis is difficult, ...
Tractament del CPNM metastàtic EFGR positiu amb inhibidors d’ITK en primera línia: informe d'avaluació de resultats
(2021)
Lung cancer (LC) is one of the most frequently diagnosed cancers worldwide. In Spain, the estimated incidence of new cases of LC for 2019 was 29,503 cases. LC remains the leading cause of cancer death in Spain in both ...
Tractament del CPNM metastàtic en primera i segona línia amb immunoteràpia: informe d'avaluació de resultats
(2021)
Lung cancer (LC) is one of the most frequently diagnosed cancers worldwide. In Spain, the estimated incidence of LC for 2019 was 29,503 new cases. LC remains the leading cause of cancer death in Spain in both sexes, with ...
Formoterol/bromur de glicopirroni/budesonida per al tractament de manteniment de la malaltia pulmonar obstructiva crònica
(2022-02-01)
Formoterol / glycopyrronium bromide / budesonide (FOR / GLIC / BUD) is a fixed-dose combination (CDF) of a long-acting beta-2-adrenergic agonist (LABA), a long-acting muscarinic antagonist (LAMA). and an inhaled corticosteroid ...
Dupilumab per al tractament de l’asma greu no controlada
(2022-01-01)
Uncontrolled severe asthma (AGNC) is defined as the disease that persists in poorly controlled despite receiving treatment with a combination of a high-dose inhaled corticosteroid (CI) and a long-acting beta-2-adrenergic ...
Prestació de micropigmentació del complex arèola-mugró 3D: aplicació al SISCAT en la reconstrucció postmastectomia oncològica
(2021-07)
This paper on the micropigmentation of the areola-nipple complex (micro CAM) 3D summarizes the most relevant elements in terms of this benefit, which has recently entered the portfolio of services of the National Health ...
Tractament de malalties minoritàries amb medicaments d'autorització individual a l'any 2021: informe d'avaluació de resultats
(2022-02)
Minority diseases pose a major challenge to the health system, as they often have a genetic origin, can affect many organs, be serious, pose a vital threat, or be chronically debilitating. Their diagnosis is difficult, ...